Literature DB >> 7766538

Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset.

J Wei1, H Xu, C N Ramchand, G P Hemmings.   

Abstract

The concentrations of serum tyrosine, phenylalanine and tryptophan have been determined in 23 male neuroleptic-free patients with schizophrenia and 28 male healthy control subjects. Tyrosine was significantly lower in neuroleptic-free patients with an early onset (starting before adulthood) than in healthy control subjects (p < 0.05), and the ratio of tyrosine to phenylalanine was significantly lower in neuroleptic-free patients with an early onset than in those with a late onset (starting at adulthood). No significant differences in these three amino acids were found between the patients with a late onset and healthy control subjects. The present findings suggest that there may be a disturbance of balance between tyrosine and phenylalanine in early-onset patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766538     DOI: 10.1016/0920-9964(94)00080-r

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

Authors:  Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache
Journal:  Pteridines       Date:  2016-10-21       Impact factor: 0.581

2.  Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms.

Authors:  Bensu Karahalil; Aylin Elkama; Mehmet Ak; Emirhan Nemutlu
Journal:  Toxicol Res (Camb)       Date:  2022-06-01       Impact factor: 2.680

3.  Peripheral amino Acid levels in schizophrenia and antipsychotic treatment.

Authors:  Vincenzo De Luca; Emanuela Viggiano; Giovanni Messina; Alessandro Viggiano; Carol Borlido; Andrea Viggiano; Marcellino Monda
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

4.  13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.

Authors:  T Teraishi; Y Ozeki; H Hori; D Sasayama; S Chiba; N Yamamoto; H Tanaka; Y Iijima; J Matsuo; Y Kawamoto; Y Kinoshita; K Hattori; M Ota; M Kajiwara; S Terada; T Higuchi; H Kunugi
Journal:  Transl Psychiatry       Date:  2012-05-22       Impact factor: 6.222

5.  Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?

Authors:  Olaoluwa Okusaga; Olesja Muravitskaja; Dietmar Fuchs; Ayesha Ashraf; Sarah Hinman; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Jason Schiffman; Elliot Hong; Gloria Reeves; Maureen Groer; Robert Dantzer; Dan Rujescu; Teodor T Postolache
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

6.  Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.

Authors:  Ashwin Jacob Mathai; Jyoti Kanwar; Olaoluwa Okusaga; Dietmar Fuchs; Christopher A Lowry; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Claudia Gragnoli; Gloria M Reeves; Maureen W Groer; Richard N Rosenthal; Dan Rujescu; Teodor T Postolache
Journal:  Front Public Health       Date:  2016-08-30

7.  Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis.

Authors:  Liisa Leppik; Kärt Kriisa; Kati Koido; Kadri Koch; Kärolin Kajalaid; Liina Haring; Eero Vasar; Mihkel Zilmer
Journal:  Front Psychiatry       Date:  2018-04-24       Impact factor: 4.157

8.  Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.

Authors:  Madis Parksepp; Liisa Leppik; Kadri Koch; Kärt Uppin; Raul Kangro; Liina Haring; Eero Vasar; Mihkel Zilmer
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379

Review 9.  Toxoplasma gondii, Suicidal Behavior, and Intermediate Phenotypes for Suicidal Behavior.

Authors:  Teodor T Postolache; Abhishek Wadhawan; Dan Rujescu; Andrew J Hoisington; Aline Dagdag; Enrique Baca-Garcia; Christopher A Lowry; Olaoluwa O Okusaga; Lisa A Brenner
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.